{"id":"W2103541662","doi":"10.1111/j.1398-9995.2004.00550.x","title":"Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR","year":2004,"lang":"en","type":"article","venue":"Allergy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Novartis Pharma; Novartis","keywords":"Omalizumab; Medicine; Tolerability; Concomitant; Asthma; Placebo; Immunoglobulin E; Adverse effect; Budesonide; Internal medicine; Quality of life (healthcare); Immunology; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00164128,0.0005886284,0.001629614,0.0002380966,0.0002988261,0.0005815482,0.0003686234,0.0008903875,0.001353675],"category_scores_gemma":[0.001646445,0.0003438985,0.001206195,0.0002073577,0.0004537604,0.0004803021,0.0002341392,0.001011601,0.0002520596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003915887,"about_ca_system_score_gemma":0.0004015578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003003457,"about_ca_topic_score_gemma":0.000566344,"domain_scores_codex":[0.9994304,0.0002760726,0.00006383811,0.00007353618,0.00008629194,0.00006983604],"domain_scores_gemma":[0.9991404,0.0003121008,0.0002854506,0.00004266158,0.00003587125,0.000183526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7184749,0.01568303,0.07916122,0.001345637,0.002837203,0.0005746748,0.0002099305,0.0009516909,0.03144574,0.00008723326,0.001039408,0.1481893],"study_design_scores_gemma":[0.3395142,0.379979,0.2659699,0.0001478468,0.00254289,0.001862143,0.0001224165,0.00227813,0.005326445,0.00009980386,0.002109082,0.00004825389],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960775,0.0031701,0.0001132405,0.00009878264,0.00003580861,0.00009232244,0.00004670752,0.00001202663,0.000353534],"genre_scores_gemma":[0.9987196,0.000527312,0.0002121744,0.0001450008,0.00009131611,0.00009137683,0.00008354957,0.000002052186,0.0001276636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00164128,"threshold_uncertainty_score":0.008679986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009714633343071146,"score_gpt":0.2134854460076604,"score_spread":0.2037708126645892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}